EUVIMEDScopri EUVIMED
Querschnittstudie

Infectious Disease Diagnostic Capacity Across Hospital Tiers in China: National Cross-Sectional Survey

Ruyi Zhang, Yu Wu, Ziyang Ren, Lieyu Huang, Yihao Zhao, Xiaoying Zheng, Jie Qian, Yajie Wang

JMIR Public Health and Surveillance · 2026-11-20 · 12 · e107757

DOI: 10.2196/107757 ↗

At a glance

Querschnittstudie in JMIR Public Health and Surveillance, published online on 2026-11-20. Written by Ruyi Zhang and 7 co-authors. 47 references.

AbstractDati bibliograficiCiteRelated studies

Abstract (original language)

Background

China's notifiable infectious disease surveillance relies on clinical recognition and diagnostic testing, but uneven hospital capacity may affect case ascertainment and interpretation of reported burden.

Objective

This study aims to assess infectious disease diagnostic capacity across hospital tiers in China, including alignment with notified disease burden, regional variation, diagnostic modalities, and implementation barriers.

Methods

We conducted a national cross-sectional web-based survey of hospitals in China in 2023. After centralized quality control and eligibility screening, 2689 hospitals were included: 124 (4.6%) primary, 1478 (55%) secondary, and 1087 (40.4%) tertiary hospitals. We assessed in-house and send-out testing availability; compared diagnostic availability with national notified incidence and mortality; and examined regional variation, selected diagnostic modalities, and reported barriers.

Results

Median in-house diagnostic coverage increased from 11.6% (IQR 9.3%-18.6%) in primary hospitals to 27.9% (IQR 18.6%-37.2%) in secondary hospitals and 39.5% (IQR 27.9%-48.8%) in tertiary hospitals; corresponding overall coverage, including send-out testing, was 14% (IQR 9.3%-23.3%), 32.6% (IQR 23.3%-44.2%), and 44.2% (IQR 30.2%-55.8%), respectively. Tier differences persisted in sensitivity analyses. Diagnostic availability was not consistently aligned with notified disease burden. In-house hepatitis B testing was available in 82.3% (102/124), 98% (1449/1478), and 99.3% (1079/1087) of primary, secondary, and tertiary hospitals, respectively. Pulmonary tuberculosis showed a pronounced tier gradient (26/124, 21% in primary vs 910/1087, 83.7% in tertiary hospitals). Hand, foot, and mouth disease and other infectious diarrheal diseases had limited availability even in tertiary hospitals (380/1087, 35% and 456/1087, 42%, respectively) despite high incidence. Some lower-incidence but high-consequence infections also had limited local capacity, including hemorrhagic fever with renal syndrome (151/1087, 13.9%) and rabies (43/1087, 4%) in tertiary hospitals. Geographic variation was partly consistent with known disease endemicity, with higher testing availability for hemorrhagic fever with renal syndrome in northeastern hospitals, although only 35.9% (55/153) of tertiary hospitals in this region offered in-house testing. Diagnostic depth also varied across tiers: hepatitis B virus (HBV) DNA testing increased from 8.1% (10/124) in primary hospitals to 61.1% (664/1087) in tertiary hospitals. For COVID-19, primary hospitals more frequently reported antigen than nucleic acid testing (57/124, 46% vs 27/124, 21.8%). Lower-tier hospitals more often reported workforce and infrastructure constraints, whereas tertiary hospitals more frequently cited reagent-licensing and fee-schedule barriers.

Conclusions

Among surveyed hospitals, infectious disease diagnostic capacity differed substantially across hospital tiers, varied geographically, and was not consistently aligned with notified disease burden. These disparities extended beyond disease coverage to specific testing modalities and barriers to capacity expansion. These findings support tiered, regionally responsive diagnostic networks that provide essential testing closer to first-contact care while ensuring timely access to specialized diagnostics through reliable, quality-assured referral pathways.

Cite

APA

Zhang, R., Wu, Y., Ren, Z., Huang, L., Zhao, Y., Zheng, X., Qian, J., & Wang, Y. (2026). Infectious Disease Diagnostic Capacity Across Hospital Tiers in China: National Cross-Sectional Survey. JMIR Public Health and Surveillance, 12, e107757. https://doi.org/10.2196/107757

Vancouver

Zhang R, Wu Y, Ren Z, Huang L, Zhao Y, Zheng X, et al. Infectious Disease Diagnostic Capacity Across Hospital Tiers in China: National Cross-Sectional Survey. JMIR Public Health and Surveillance. 2026;12:e107757. doi:10.2196/107757

BibTeX
@article{Zhang2026,
  author = {Zhang, Ruyi and Wu, Yu and Ren, Ziyang and Huang, Lieyu and Zhao, Yihao and Zheng, Xiaoying and Qian, Jie and Wang, Yajie},
  title = {Infectious Disease Diagnostic Capacity Across Hospital Tiers in China: National Cross-Sectional Survey},
  journal = {JMIR Public Health and Surveillance},
  year = {2026},
  volume = {12},
  pages = {e107757},
  doi = {10.2196/107757}
}
Start for free →